Could a glass of special milk help prevent colon cancer?
NCT ID NCT04824053
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether a special milk called UNICLA-A2 can reduce inflammation and improve gut health in people at high risk for colorectal cancer who have already had polyps removed. The milk comes from cows with a specific protein type and is enriched with omega-3 and selenium. Over 3 months, 34 participants will drink either this special milk or regular milk to see if it lowers inflammatory markers and supports a healthier gut microbiome.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
UNICLA-A2 milk (from cows with A2 beta-casein, enriched with omega-3 and selenium)
What this could lead to
If it works, this could point toward a dietary approach to lower inflammation and cancer risk in people who have had colon polyps removed.
What could go wrong
This is a small, early-phase trial with only 34 participants, so results may not apply widely. The intervention is just a dietary supplement, so any effect is likely modest.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL POLYP are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Angel Lanas Arbeloa
RECRUITINGZaragoza, Zaragoza, 50009, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••